Deal Details
Follow-On Offering
Summary
Baird served as co-manager on this offering.
About
INC Research Holdings, Inc. (“INC Research” or the “Company”) (NASDAQ-GS: INCR) recently completed a follow-on offering of 8,050,000 common shares at a price of $31.00 per share generating gross proceeds of approximately $250 million. All of the shares sold in the offering were from selling shareholders. The Company will not receive any proceeds from the offering. INC Research is a global contract research organization exclusively focused on Phase I to Phase IV clinical development services for the biopharmaceutical and medical device industries. The Company leverages its breadth of service offerings and its depth of therapeutic expertise across multiple patient populations to connect customers, clinical research sites and patients to accelerate the delivery of new medicines to market. INC Research is headquartered in Raleigh, North Carolina.For additional information about this transaction, please contact:
- Date
- May 2015
- Company
- INC Research Holdings, Inc.
- Transaction
- M&A
- Sectors
- Healthcare
- Target Geography
- North America
Share
